Skip to content

Exclusive nutritional therapy and intestinal homeostasis in pediatric inflammatory bowel disease

Exclusive nutritional therapy and intestinal homeostasis in pediatric inflammatory bowel disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00003548
Enrollment
20
Registered
2012-02-17
Start date
2012-02-20
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K50.9

Interventions

Group 1: Non-interventional study with children and adolescents treated for six to eight weeks with exclusive enteral nutrition for induction of remission of active crohn's disease. Before initiation

Sponsors

Klinikum der Universität München, Dr. von Haunersches Kinderspital; Abteilung für pädiatrische Gastroenterologie und Hepatologie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 20 Years

Inclusion criteria

Inclusion criteria: - Patients suffering from active inflammatory bowel disease and need to be treated with exclusive enteral nutrition therapy, steroids or biologicals; - Diagnosis confirmed by Porto diagnostic criteria; - informed consent of patients (> 12 years of age) and parents.

Exclusion criteria

Exclusion criteria: Changes in the immunosuppressive medication during the last three month.

Design outcomes

Primary

MeasureTime frame
Parameters will be evaluated before and 2-6 weeks after initiation of therapy: 1. Gut microbiome composition before and during therapy (method: sequencing). 2. Mucosal inflammation on molecular and cellular level (methods: quantitative PCR, immunohistochemistry). 3. Phenotype and Function of peripheral blood mononuclear cells (methods: FACS analysis, ELISA, qPCR).

Secondary

MeasureTime frame
Clinical and laboratory remission after 2-6 weeks of therapy; methods: history and examination, disease activity score, stool and lab work for inflammatory markers;

Countries

Germany

Contacts

Public ContactTobias Schwerd

Klinikum der Universität München, Dr. von Haunersches Kinderspital; Abteilung für pädiatrische Gastroenterologie und Hepatologie

tobias.schwerd@med.lmu.de+4989 5160 7975 oder 2811 (Pforte)

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026